NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 1, 2025 — Medicaid faces severe threats that could leave 89 million Americans vulnerable. Dr. Susan Reynolds warns of devastating cuts to rural hospitals and coverage losses impacting communities nationwide.
September 30, 2025 — Fifty 1 Labs acquires BioSpark AI Technologies, gaining patented AI systems for clinical data analysis and LLM ensemble technology to advance AI-powered healthcare solutions and drug discovery.
September 30, 2025 — Lantern Pharma receives FDA guidance for pediatric brain cancer therapy LP-184/STAR-001, plans 2026 trial launch. Company advancing multiple cancer treatments using computational biology platform.
September 30, 2025 — Scorpion venom shows promise in treating aggressive brain cancer. Researchers at City of Hope and CNS Pharmaceuticals are developing new therapies using chlorotoxin from scorpion venom to target glioblastoma tumors.
September 30, 2025 — Tonix Pharmaceuticals receives FDA clearance for Phase 2 trial of TNX-2900 for Prader-Willi syndrome, a rare genetic disorder causing childhood obesity with Orphan Drug designation.
September 30, 2025 — Soligenix expands European Medical Advisory Board for HyBryte™ Phase 3 trial in cutaneous T-cell lymphoma. Late-stage biopharma company advances novel photodynamic therapy.
September 30, 2025 — Branded Legacy files patent for innovative air-powered intranasal drug delivery device designed for precise dosing of medications including naloxone and unstable formulations requiring reconstitution.
September 30, 2025 — GeoVax Labs raises $2.5M to advance COVID-19 vaccines for immunocompromised patients and cancer immunotherapies. Funding supports Phase 2 trials and novel treatments.
September 30, 2025 — Doctorpresso unveils Therapods AI therapy earbuds at CES 2026. World's first AI-powered earbuds for virtual group therapy with real-time emotion sensing at lower costs.
September 30, 2025 — ArcticCollagen's marine collagen supplement combines 8,000mg collagen, hyaluronic acid & vitamin C. Backed by science, improves skin elasticity & hydration. Available on Amazon & major retailers.
September 29, 2025 — Alameda Health System's nursing homes earn Newsweek's 2026 Best Nursing Homes recognition while facing $100M annual Medicaid cuts. Learn about quality care and funding challenges.
September 29, 2025 — NeuroOne Medical Technologies announces October 7 virtual investor webinar discussing FDA clearance, business updates & neurological treatment innovations for epilepsy & Parkinson's disease.
September 29, 2025 — HeartBeam develops first cable-free 12-lead ECG system for home cardiac monitoring. Portable device enables comprehensive arrhythmia assessment outside clinical settings.
September 29, 2025 — TriNetX named among Top 25 Healthcare Software Companies of 2025 for its innovative clinical trial platform using real-world data from 300M+ patients to accelerate drug development.
September 29, 2025 — Strawberry Fields REIT celebrates 10 years with 11% annual AFFO growth. CEO Moishe Gubin discusses strategic growth and commitment to serving America's aging population through skilled nursing facilities.
September 29, 2025 — Soligenix advances SGX302 psoriasis treatment in phase 2 trial. Learn about this novel therapeutic option for autoimmune skin conditions and its potential impact on patient care.
September 29, 2025 — Quantum BioPharma (QNTM) announces 2025 shareholder meeting results with strong turnout. Company advancing Lucid-MS for multiple sclerosis treatment and maintains strategic investments.
September 29, 2025 — The Caregiver Foundation hosts Starlight Fancies 2025 fundraiser on Nov 1 to support Hawai'i's elders & disabled. Features food, music & auction.
September 29, 2025 — GeoVax Labs supports America First Global Health Strategy with vaccine pipeline including Mpox/smallpox and COVID-19 vaccines. Company's advanced manufacturing addresses biodefense vulnerabilities.
September 29, 2025 — UCSF cardiologist Dr. Megan McLaughlin wins 2025 Dr. Nanette K. Wenger Research Goes Red Award for study revealing postpartum care disparities in women with pregnancy hypertension.